Quick Answer
Enveric Biosciences, Inc. reported Stockholders Equity of $4.18 million for fiscal year 2025.
Enveric Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.18M | +162.3% |
| 2024 | $1.59M | -18.6% |
| 2023 | $1.96M | -86.7% |
| 2022 | $14.67M | -34.2% |
| 2021 | $22.31M | +553.1% |
| 2020 | $3.42M | +288.5% |
| 2019 | -$1.81M | -2667.7% |
| 2018 | -$65.5K | -100.3% |
| 2017 | $19.45M | +66.7% |
| 2016 | $11.66M | +4411.5% |
| 2015 | $258.5K | +6778.7% |
| 2014 | -$3.9K | +80.9% |
| 2013 | -$20.2K | -0.8% |
| 2012 | -$20.1K | -540.5% |
| 2011 | $4.6K | +109.2% |
| 2010 | -$49.5K | -391.5% |
| 2009 | -$10.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.46M | -12.5% | +58.2% |
| June 30, 2025 | $2.18M | -59.6% | -44.2% |
| March 31, 2025 | $3.92M | -39.6% | +146.0% |
| December 31, 2024 | $1.59M | -18.6% | -59.7% |
| September 30, 2024 | $3.95M | +62.2% | -26.9% |
| June 30, 2024 | $5.41M | +10.9% | -16.6% |
| March 31, 2024 | $6.48M | -37.7% | +231.3% |
| December 31, 2023 | $1.96M | -86.7% | -19.7% |
- Enveric Biosciences, Inc. showed an increase of +162.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Enveric Biosciences, Inc.’s stockholders equity has grown by 41564.4% (from -$10.1 thousand to $4.18 million).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: